Gallagher Ciara, Murphy Catherine, O'Brien Fergal J, Piskareva Olga
Cancer Bioengineering Group, Department of Anatomy and Regenerative Medicine, RCSI University of Medicine and Health Sciences, Dublin, Ireland; School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland; Tissue Engineering Research Group, Department of Anatomy and Regenerative Medicine, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
Tissue Engineering Research Group, Department of Anatomy and Regenerative Medicine, RCSI University of Medicine and Health Sciences, Dublin, Ireland; Trinity Centre for Bioengineering, Trinity College Dublin, Dublin, Ireland; Advanced Materials and Bioengineering Research Centre (AMBER), RCSI and TCD, Dublin, Ireland.
J Vis Exp. 2021 Jul 9(173). doi: 10.3791/62627.
Neuroblastoma is the most common extracranial solid tumor in children, accounting for 15% of overall pediatric cancer deaths. The native tumor tissue is a complex three-dimensional (3D) microenvironment involving layers of cancerous and non-cancerous cells surrounded by an extracellular matrix (ECM). The ECM provides physical and biological support and contributes to disease progression, patient prognosis, and therapeutic response. This paper describes a protocol for assembling a 3D scaffold-based system to mimic the neuroblastoma microenvironment using neuroblastoma cell lines and collagen-based scaffolds. The scaffolds are supplemented with either nanohydroxyapatite (nHA) or glycosaminoglycans (GAGs), naturally found at high concentrations in the bone and bone marrow, the most common metastatic sites of neuroblastoma. The 3D porous structure of these scaffolds allows neuroblastoma cell attachment, proliferation and migration, and the formation of cell clusters. In this 3D matrix, the cell response to therapeutics is more reflective of the in vivo situation. The scaffold-based culture system can maintain higher cell densities than conventional two-dimensional (2D) cell culture. Therefore, optimization protocols for initial seeding cell numbers are dependent on the desired experimental timeframes. The model is monitored by assessing cell growth via DNA quantification, cell viability via metabolic assays, and cell distribution within the scaffolds via histological staining. This model's applications include the assessment of gene and protein expression profiles as well as cytotoxicity testing using conventional drugs and miRNAs. The 3D culture system allows for the precise manipulation of cell and ECM components, creating an environment more physiologically similar to native tumor tissue. Therefore, this 3D in vitro model will advance the understanding of the disease pathogenesis and improve the correlation between results obtained in vitro, in vivo in animal models, and human subjects.
神经母细胞瘤是儿童最常见的颅外实体瘤,占儿童癌症总死亡人数的15%。原发肿瘤组织是一个复杂的三维(3D)微环境,由癌性和非癌性细胞层组成,周围环绕着细胞外基质(ECM)。ECM提供物理和生物学支持,并有助于疾病进展、患者预后和治疗反应。本文描述了一种使用神经母细胞瘤细胞系和基于胶原蛋白的支架组装基于3D支架的系统以模拟神经母细胞瘤微环境的方案。这些支架补充有纳米羟基磷灰石(nHA)或糖胺聚糖(GAGs),它们在神经母细胞瘤最常见的转移部位骨骼和骨髓中天然存在高浓度。这些支架的3D多孔结构允许神经母细胞瘤细胞附着、增殖和迁移,并形成细胞簇。在这个3D基质中,细胞对治疗药物的反应更能反映体内情况。基于支架的培养系统可以维持比传统二维(2D)细胞培养更高的细胞密度。因此,初始接种细胞数量的优化方案取决于所需的实验时间框架。通过DNA定量评估细胞生长、通过代谢测定评估细胞活力以及通过组织学染色评估支架内的细胞分布来监测该模型。该模型的应用包括评估基因和蛋白质表达谱以及使用传统药物和微小RNA进行细胞毒性测试。3D培养系统允许对细胞和ECM成分进行精确操作,创造一个在生理上更类似于天然肿瘤组织的环境。因此,这个3D体外模型将促进对疾病发病机制的理解,并改善在体外、动物模型体内和人类受试者中获得的结果之间的相关性。